Variant report

Variant	nsv886945
Chromosome Location	chr6:167638337-167742278
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1451)
CpG islands
(count:2627)
Chromatin interactive
region (count:19)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1451 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:167652605-167653007	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:167704338-167705733	HepG2	liver:	n/a	n/a
3	ARID3A	chr6:167723215-167724601	HepG2	liver:	n/a	n/a
4	ARID3A	chr6:167699867-167700232	HepG2	liver:	n/a	n/a
5	ARID3A	chr6:167645950-167646149	HepG2	liver:	n/a	n/a
6	ARID3A	chr6:167682223-167682912	HepG2	liver:	n/a	n/a
7	ARID3A	chr6:167655013-167655211	HepG2	liver:	n/a	n/a
8	ARID3A	chr6:167702230-167702578	HepG2	liver:	n/a	n/a
9	ARID3A	chr6:167651727-167651738	HepG2	liver:	n/a	n/a
10	ARID3A	chr6:167722138-167722657	HepG2	liver:	n/a	n/a
11	ATF1	chr6:167727339-167727444	K562	blood:	n/a	n/a
12	ATF1	chr6:167702337-167702425	K562	blood:	n/a	n/a
13	ATF2	chr6:167651500-167652487	H1-hESC	embryonic stem cell:	n/a	n/a
14	ATF2	chr6:167641353-167641826	H1-hESC	embryonic stem cell:	n/a	n/a
15	ATF2	chr6:167641333-167641936	H1-hESC	embryonic stem cell:	n/a	n/a
16	BACH1	chr6:167702257-167702472	H1-hESC	embryonic stem cell:	n/a	n/a
17	BACH1	chr6:167641591-167641850	H1-hESC	embryonic stem cell:	n/a	n/a
18	BATF	chr6:167702166-167702414	GM12878	blood:	n/a	n/a
19	BATF	chr6:167726056-167726329	GM12878	blood:	n/a	n/a
20	BATF	chr6:167726053-167726251	GM12878	blood:	n/a	n/a
21	BCL3	chr6:167710341-167710705	GM12878	blood:	n/a	n/a
22	BHLHE40	chr6:167682232-167682824	HepG2	liver:	n/a	n/a
23	BHLHE40	chr6:167723177-167724281	HepG2	liver:	n/a	n/a
24	BHLHE40	chr6:167722070-167722725	HepG2	liver:	n/a	chr6:167722523-167722539
25	BHLHE40	chr6:167733252-167733970	HepG2	liver:	n/a	n/a
26	BHLHE40	chr6:167702270-167702451	K562	blood:	n/a	n/a
27	BHLHE40	chr6:167722146-167722527	HepG2	liver:	n/a	n/a
28	BHLHE40	chr6:167702264-167702463	HepG2	liver:	n/a	n/a
29	BHLHE40	chr6:167733370-167733629	HepG2	liver:	n/a	n/a
30	BHLHE40	chr6:167732490-167732554	GM12878	blood:	n/a	n/a
31	BHLHE40	chr6:167723198-167723690	HepG2	liver:	n/a	n/a
32	BHLHE40	chr6:167691769-167691891	K562	blood:	n/a	chr6:167691854-167691867
33	BHLHE40	chr6:167699851-167700081	HepG2	liver:	n/a	n/a
34	BHLHE40	chr6:167704696-167705644	HepG2	liver:	n/a	n/a
35	BRCA1	chr6:167722055-167722521	HepG2	liver:	n/a	n/a
36	CBX3	chr6:167669429-167669771	K562	blood:	n/a	n/a
37	CBX3	chr6:167708762-167709384	K562	blood:	n/a	n/a
38	CBX3	chr6:167708857-167709379	K562	blood:	n/a	n/a
39	CBX3	chr6:167702109-167702642	K562	blood:	n/a	n/a
40	CEBPB	chr6:167639673-167640002	HepG2	liver:	n/a	chr6:167639837-167639848 chr6:167639839-167639848 chr6:167639839-167639850
41	CEBPB	chr6:167723167-167723598	HepG2	liver:	n/a	n/a
42	CEBPB	chr6:167705083-167705467	HepG2	liver:	n/a	chr6:167705263-167705276 chr6:167705265-167705274 chr6:167705263-167705274
43	CEBPB	chr6:167658239-167658916	H1-hESC	embryonic stem cell:	n/a	n/a
44	CEBPB	chr6:167723191-167723562	HepG2	liver:	n/a	n/a
45	CEBPB	chr6:167639685-167640004	H1-hESC	embryonic stem cell:	n/a	chr6:167639837-167639848 chr6:167639839-167639848 chr6:167639839-167639850
46	CEBPB	chr6:167705118-167705446	H1-hESC	embryonic stem cell:	n/a	chr6:167705263-167705276 chr6:167705265-167705274 chr6:167705263-167705274
47	CEBPB	chr6:167693339-167693586	A549	lung:	n/a	chr6:167693472-167693481 chr6:167693471-167693482 chr6:167693470-167693481
48	CEBPB	chr6:167693298-167693629	ECC-1	luminal epithelium:	n/a	chr6:167693472-167693481 chr6:167693471-167693482 chr6:167693470-167693481 chr6:167693601-167693614
49	CEBPB	chr6:167722079-167722628	HepG2	liver:	n/a	n/a
50	CEBPB	chr6:167693341-167693644	HepG2	liver:	n/a	chr6:167693472-167693481 chr6:167693471-167693482 chr6:167693470-167693481 chr6:167693601-167693614

(count:2627 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:167649336-167649386	NB4	blood:	n/a
2	chr6:167710360-167710410	NB4	blood:	n/a
3	chr6:167738277-167738327	HAEpiC	amniotic membrane:	n/a
4	chr6:167653907-167653957	HMEC	breast:	n/a
5	chr6:167649336-167649386	NB4	blood:	n/a
6	chr6:167710360-167710410	NB4	blood:	n/a
7	chr6:167738277-167738327	HAEpiC	amniotic membrane:	n/a
8	chr6:167653907-167653957	HMEC	breast:	n/a
9	chr6:167652028-167652078	AG04450	lung:	fetal
10	chr6:167738592-167738642	Jurkat	blood:	n/a
11	chr6:167710360-167710410	GM12878	blood:	n/a
12	chr6:167649631-167649681	AoSMC	blood vessel:	n/a
13	chr6:167739618-167739668	GM12891	blood:	n/a
14	chr6:167680455-167680505	MCF-7	breast:	n/a
15	chr6:167708827-167708877	HIPEpiC	eye:	n/a
16	chr6:167649749-167649799	LNCaP	prostate:	n/a
17	chr6:167649384-167649434	PANC-1	pancreas:	n/a
18	chr6:167734054-167734104	SK-N-SH	brain:	n/a
19	chr6:167704808-167704858	HEEpiC	esophagus:	n/a
20	chr6:167653957-167654007	LNCaP	prostate:	n/a
21	chr6:167739618-167739668	NHBE	bronchial:	n/a
22	chr6:167661905-167661955	Hela-S3	cervix:	n/a
23	chr6:167655290-167655340	NB4	blood:	n/a
24	chr6:167738594-167738644	HRPEpiC	eye:	n/a
25	chr6:167680455-167680505	LNCaP	prostate:	n/a
26	chr6:167653982-167654032	IMR90	lung:	fetal
27	chr6:167710360-167710410	ProgFib	skin:	n/a
28	chr6:167737937-167737987	LNCaP	prostate:	n/a
29	chr6:167727700-167727750	PFSK-1	brain:	n/a
30	chr6:167738425-167738475	SKMC	muscle:	n/a
31	chr6:167704769-167704819	AoSMC	blood vessel:	n/a
32	chr6:167649336-167649386	CMK	blood:	n/a
33	chr6:167680447-167680497	HRE	kidney:	n/a
34	chr6:167703591-167703641	AG09309	skin:	n/a
35	chr6:167738594-167738644	Hepatocyte	liver:	n/a
36	chr6:167680455-167680505	CMK	blood:	n/a
37	chr6:167649256-167649306	AG09309	skin:	n/a
38	chr6:167738425-167738475	AG04450	lung:	fetal
39	chr6:167695026-167695076	SK-N-MC	brain:	n/a
40	chr6:167710360-167710410	HIPEpiC	eye:	n/a
41	chr6:167704769-167704819	GM12892	blood:	n/a
42	chr6:167653957-167654007	Caco-2	colon:	n/a
43	chr6:167705750-167705800	IMR90	lung:	fetal
44	chr6:167654977-167655027	GM06990	blood:	n/a
45	chr6:167718461-167718511	HCF	heart:	n/a
46	chr6:167649749-167649799	T-47D	breast:	n/a
47	chr6:167738592-167738642	Hela-S3	cervix:	n/a
48	chr6:167658907-167658957	PFSK-1	brain:	n/a
49	chr6:167727700-167727750	CMK	blood:	n/a
50	chr6:167703894-167703944	NHDF-neo	bronchial:	n/a

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:167702039..167702568-chr6:167764606..167765474,2	MCF-7	breast:
2	chr6:167631565..167632072-chr6:167702069..167702692,3	K562	blood:
3	chr6:167636874..167638495-chr6:167694115..167696567,2	K562	blood:
4	chr6:167662732..167663315-chr6:167819023..167819880,2	K562	blood:
5	chr6:167715327..167717333-chr6:167717541..167719931,2	MCF-7	breast:
6	chr6:167703616..167705764-chr6:167717598..167719278,2	MCF-7	breast:
7	chr6:167668192..167671777-chr6:167684157..167687082,3	K562	blood:
8	chr1:28836187..28837925-chr6:167694572..167696254,2	K562	blood:
9	chr6:167615262..167616947-chr6:167733556..167735117,2	MCF-7	breast:
10	chr6:167734899..167737753-chr6:167743376..167745822,2	MCF-7	breast:
11	chr6:167662535..167665478-chr6:167668701..167671430,2	K562	blood:
12	chr6:167736614..167738249-chr6:167740426..167742938,2	K562	blood:
13	chr6:167662535..167665478-chr6:167668701..167671430,2	K562	blood:
14	chr6:167636874..167638495-chr6:167694115..167696567,2	K562	blood:
15	chr6:167736614..167738249-chr6:167740426..167742938,2	K562	blood:
16	chr6:167699179..167702166-chr6:167703091..167705361,2	K562	blood:
17	chr6:167631751..167632287-chr6:167701939..167702527,2	MCF-7	breast:
18	chr6:167669951..167671777-chr6:167683631..167687000,3	K562	blood:
19	chr6:167715327..167717333-chr6:167717541..167719931,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UNC93A-1	chr6:167655379-167655453	XLOC_005540
2	lnc-GPR31-1	chr6:167651156-167651293	XLOC_005921
3	lnc-UNC93A-1	chr6:167659275-167659404	XLOC_005540
4	lnc-GPR31-1	chr6:167653636-167653833	XLOC_005921
5	lnc-GPR31-1	chr6:167653688-167653968	XLOC_005921
6	lnc-GPR31-1	chr6:167650996-167651293	XLOC_005921

No data

Variant related genes	Relation type
UNC93A	TF binding region
ENSG00000228648	TF binding region
TTLL2	TF binding region
ENSG00000231720	TF binding region
UNC93A	CpG island
ENSG00000228648	CpG island
TTLL2	CpG island
ENSG00000231720	CpG island
ENSG00000112494	chromatin interactions
ENSG00000180198	chromatin interactions
CYBASC3	miRNA target sites
CYB5R4	miRNA target sites

Extended variants
information (count: 5292 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:5292 , 50 per page) page: 1 2 3 4 5 6 7 ... 106

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9366117	chr6:167638337-167638338	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs372860471	chr6:167638344-167638345	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs188471727	chr6:167638355-167638356	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs575086067	chr6:167638385-167638386	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs553735048	chr6:167638420-167638421	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs572136461	chr6:167638423-167638424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs540133712	chr6:167638436-167638437	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs10669644	chr6:167638465-167638466	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs555286030	chr6:167638466-167638467	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs71299765	chr6:167638467-167638468	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs7758245	chr6:167638494-167638495	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs544081557	chr6:167638496-167638497	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs562578164	chr6:167638546-167638547	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs567744640	chr6:167638555-167638556	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs576010047	chr6:167638563-167638564	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs145034402	chr6:167638592-167638593	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs181187613	chr6:167638611-167638612	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs527322734	chr6:167638619-167638620	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs111549247	chr6:167638626-167638627	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs5881734	chr6:167638635-167638636	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs397758803	chr6:167638636-167638637	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs77862082	chr6:167638637-167638638	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs567866786	chr6:167638684-167638685	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs531904040	chr6:167638698-167638699	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs550122445	chr6:167638703-167638704	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs571845731	chr6:167638730-167638731	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs75668599	chr6:167638784-167638785	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs76953818	chr6:167638792-167638793	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs546566511	chr6:167638803-167638804	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs374052189	chr6:167638804-167638805	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs565727629	chr6:167638805-167638806	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs536258692	chr6:167638834-167638835	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs9459929	chr6:167638879-167638880	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs186149921	chr6:167638911-167638912	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs564760656	chr6:167638923-167638924	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs556061902	chr6:167638932-167638933	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs577812243	chr6:167638938-167638939	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs77274735	chr6:167638982-167638983	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs560298630	chr6:167638992-167638993	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs190623585	chr6:167639017-167639018	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs71554329	chr6:167639066-167639067	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs542665534	chr6:167639089-167639090	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs540405746	chr6:167639133-167639134	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs561592795	chr6:167639158-167639159	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs531897247	chr6:167639159-167639160	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs6905218	chr6:167639162-167639163	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs565335021	chr6:167639214-167639215	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs9355619	chr6:167639215-167639216	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs547448100	chr6:167639229-167639230	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs9356572	chr6:167639232-167639233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:1138 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167628200-167638600	Weak transcription	Fetal Brain Female	brain
2	chr6:167635400-167639600	Weak transcription	Rectal Mucosa Donor 31	rectum
3	chr6:167636400-167638600	Enhancers	iPS-20b Cell Line	embryonic stem cell
4	chr6:167636400-167641000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr6:167636600-167639600	Enhancers	ES-I3 Cell Line	embryonic stem cell
6	chr6:167636600-167639600	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr6:167636800-167639600	Enhancers	HUES48 Cell Line	embryonic stem cell
8	chr6:167636800-167639600	Enhancers	iPS-15b Cell Line	embryonic stem cell
9	chr6:167636800-167639800	Enhancers	H1 Cell Line	embryonic stem cell
10	chr6:167636800-167639800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr6:167636800-167639800	Enhancers	Thymus	Thymus
12	chr6:167636800-167640000	Enhancers	Fetal Thymus	thymus
13	chr6:167636800-167640800	Enhancers	HUVEC	blood vessel
14	chr6:167637000-167638800	Weak transcription	Fetal Brain Male	brain
15	chr6:167637000-167639600	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr6:167637200-167641000	Enhancers	H9 Cell Line	embryonic stem cell
17	chr6:167637200-167641600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr6:167637400-167638800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr6:167637400-167639400	Weak transcription	Placenta Amnion	Placenta Amnion
20	chr6:167637600-167638600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
21	chr6:167637600-167638600	Weak transcription	Fetal Intestine Small	intestine
22	chr6:167637600-167639000	Weak transcription	Fetal Intestine Large	intestine
23	chr6:167637600-167639000	Weak transcription	Gastric	stomach
24	chr6:167637600-167640200	Enhancers	HepG2	liver
25	chr6:167637800-167638800	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr6:167637800-167643200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr6:167638000-167638400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr6:167638000-167638400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
29	chr6:167638200-167639200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
30	chr6:167638200-167640000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr6:167638400-167640000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr6:167638400-167640000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr6:167638600-167639200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
34	chr6:167638600-167640000	Enhancers	Fetal Brain Female	brain
35	chr6:167638600-167640200	Enhancers	Fetal Intestine Small	intestine
36	chr6:167638600-167640600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr6:167638800-167639200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
38	chr6:167638800-167639600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr6:167638800-167640200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr6:167638800-167640800	Enhancers	Fetal Brain Male	brain
41	chr6:167639000-167639200	Enhancers	Gastric	stomach
42	chr6:167639000-167640200	Enhancers	Fetal Intestine Large	intestine
43	chr6:167639200-167639600	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr6:167639200-167639600	Enhancers	iPS-20b Cell Line	embryonic stem cell
45	chr6:167639200-167639800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
46	chr6:167639400-167640000	Enhancers	Placenta Amnion	Placenta Amnion
47	chr6:167639600-167640000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
48	chr6:167639600-167640000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr6:167639600-167640000	Enhancers	Rectal Mucosa Donor 31	rectum
50	chr6:167639600-167640600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links